Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Convertible Debt: 2023-2025

Historic Convertible Debt for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to -$2.5 million.

  • Abivax's Convertible Debt rose 47.43% to -$2.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.5 million, marking a year-over-year increase of 47.43%. This contributed to the annual value of $25.0 million for FY2024, which is 21.60% down from last year.
  • Abivax's Convertible Debt amounted to -$2.5 million in Q2 2025, which was down 7.61% from -$2.3 million recorded in Q1 2025.
  • Abivax's Convertible Debt's 5-year high stood at $31.9 million during Q4 2023, with a 5-year trough of -$4.7 million in Q2 2024.
  • Its 3-year average for Convertible Debt is $7.5 million, with a median of -$2.3 million in 2024.
  • Its Convertible Debt has fluctuated over the past 5 years, first dropped by 21.60% in 2024, then soared by 47.43% in 2025.
  • Quarterly analysis of 3 years shows Abivax's Convertible Debt stood at $31.9 million in 2023, then dropped by 21.60% to $25.0 million in 2024, then soared by 47.43% to -$2.5 million in 2025.
  • Its last three reported values are -$2.5 million in Q2 2025, -$2.3 million for Q1 2025, and $25.0 million during Q4 2024.